Author: Smead Capital Management

4Q23 International Value Strategy Newsletter: Recognizing Change

As we end 2023, the world looks very different than it did a few years ago. The one thing inevitable in life is change. As investors, we are required to spend a lifetime of learning. One of the things we should recognize over time is how to take advantage of change. In this shareholder letter, we hope to explain current phenomena that weren’t predicted or present just a few years ago. We hope that reminding ourselves of this will bring more clarity to the opportunities for investors ahead. […]

⟶ Keep Reading

Reuters: Bill Smead on Amgen

Amgen sales rise, but shares off as investors await obesity data By Deena Beasley For more information go to reuters.com. Stocks mentioned: AMGN The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past

⟶ Keep Reading

Bloomberg: Cole Smead, CFA on US Energy Stocks

US Oil Dealmaking at Full Tilt as Chevron Agrees to Buy Hess By David Wethe, Kevin Crowley, Mitchell Ferman, and Kiel Porter For more information go to www.bloomberg.com. Stocks mentioned: CVX, XOM, COP, DVN The information contained in this article represents SCM’s opinions, and should

⟶ Keep Reading
Scroll to Top